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Abstract

27
Synaptotagmin 2 is a synaptic vesicle protein that functions as a calcium sensor for 28 neurotransmission, but has not been previously associated with human disease. Using whole 29 exome sequencing, we identified heterozygous missense mutations in the C2B calcium-binding 30 domain of the gene encoding Synaptotagmin 2 in two multigenerational families presenting with 31 peripheral motor neuron syndromes. An essential calcium-binding aspartate residue, Asp307Ala, 32 was disrupted by a c.920T>G change in one family that presented with an autosomal dominant 33 presynaptic neuromuscular junction disorder resembling Lambert-Eaton myasthenic syndrome.
34
A c.923G>A variant affecting an adjacent residue (p.Pro308Leu) produced a presynaptic 35 neuromuscular junction defect and a dominant hereditary motor neuropathy in a second family.
36
Characterization of the homologous mutation in Drosophila Synaptotagmin revealed a dominant 37 disruption of synaptic vesicle exocytosis using this transgenic model. These 
53
In the three-generational index family USA1, affected family members developed foot Table 1 .
63
Electrophysiological studies in USA1 ( Figure 2 , segregating variants were identified in this family (Table S3) .
108
To determine how these SYT2 mutations might alter synaptic function, we focused on the domain. We generated transgenic Drosophila containing wild-type (WT) and mutant
111
Synaptotagmin genes using the GAL4-UAS expression system. Drosophila contains a single 112 isoform (DSYT1) of the mammalian synaptic vesicle SYT subfamily (SYT1, SYT2, SYT9).
113
DSYT1 is highly homologous to human SYT2, with perfect conservation of the five C2B 114 calcium binding residues, including Asp307 (corresponding to Asp362 in Drosophila, Figure 3A ,
115
Figure S1.). We generated transgenic WT and 1527A>C (p.Asp362Ala) UAS-DSyt1 lines and 116 induced these genes using the pan neuronal GAL4 driver elav C155 ( Figure 3B, C) 
Lower limb Features
, not present (-), present (+), not done (ND), facilitation with exercise (F), reduced (Red.)
, not present (-), present (+), not done (ND), facilitation with exercise (F).
Motor development and Gait:
Ankle foot orthotics (AFOs), foot orthotics (FO), knee orthotic (KO), knee surgery (K), ankle surgery (A), foot surgery (F), toe surgery (T), waddling gait (W), unable/impaired heel walk (HW) or impaired toe walk (TW), not present (-), present (+) 
Other Clinical Findings
Hearing Loss Table S2 and S3 for detailed electrophysiologic findings. Facilitation denotes an increase in tendon reflexes, strength or CMAP amplitude following 10 seconds of maximal voluntary contraction. USA II.1, a 49 year old male and the husband of the proband, UK III.3 (a 24 year old male and brother of the proband) and UK III.8 (a 9 year old female cousin of the proband) are unaffected with no neurologic symptoms or signs and no foot deformities.
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